<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000439437"><TermName>fotemustine</TermName><TermPronunciation>(foh-teh-MUS-teen)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of advanced melanoma, glioblastoma (a type of brain tumor) that has come back, and certain types of lymphoma. Fotemustine damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000732999" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fotemustine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000733000" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fotemustina&quot;" language="es" id="_4"/><SpanishTermName>fotemustina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del melanoma en estadio avanzado, el glioblastoma (un tipo de cáncer cerebral) que volvió y ciertos tipos de linfoma. La fotemustina daña el ADN de las células y puede destruir las células cancerosas. Es un tipo de alquilante y de nitrosourea.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-07-08</DateFirstPublished><DateLastModified>2014-09-12</DateLastModified></GlossaryTerm>
